//
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
Circadian-Regulated Cell Death in Cardiovascular Diseases